Yahoo
BSE - Delayed Quote INR

Akums Drugs and Pharmaceuticals Limited (AKUMS.BO)

731.50 -0.40 (-0.05%)
At close: 3:52:23 PM GMT+5:30
AKUMS.BO Q2 2027 earnings call
November 3, 2026 at 12:00 PM GMT+5:30
Chart Range Bar
Loading chart for AKUMS.BO
  • Previous Close 731.90
  • Open 738.65
  • Bid 731.65 x --
  • Ask 731.50 x --
  • Day's Range 724.95 - 739.00
  • 52 Week Range 410.10 - 839.25
  • Volume 5,593
  • Avg. Volume 14,107
  • Market Cap (intraday) 111.994B
  • Beta (5Y Monthly) 0.62
  • PE Ratio (TTM) 38.40
  • EPS (TTM) 19.05
  • Earnings Date --
  • Forward Dividend & Yield 1.00 (0.14%)
  • Ex-Dividend Date Jul 3, 2026
  • 1y Target Est 863.33

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form-fill-seal products, topical preparations, eye drops, dry powder injections, and gummies for therapeutic areas, such as antiinfectives, pain management, gastroenterology, orthopaedics, cardio-diabetic care, critical care, respiratory, and gynaecology. In addition, the company operates as pharmaceutical contract development and manufacturing company. Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and is based in Delhi, India.

www.akums.in

7,337

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

AKUMS.BO
61.99%
S&P BSE SENSEX (^BSESN)
11.18%

1-Year Return

AKUMS.BO
59.34%
S&P BSE SENSEX (^BSESN)
9.82%

3-Year Return

AKUMS.BO
0.90%
S&P BSE SENSEX (^BSESN)
18.12%

5-Year Return

AKUMS.BO
0.90%
S&P BSE SENSEX (^BSESN)
26.09%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 13.42B
Earnings 1.13B
Profit Margin 8.41%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
5B
10B
0.0%
2.0%
4.0%
6.0%
8.0%

Analyst Insights

View More

Analyst Price Targets

850.00
863.33 Average
731.50 Current
880.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.48%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    45.04B

  • Net Income Avi to Common (ttm)

    2.92B

  • Diluted EPS (ttm)

    19.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    16.81B

  • Total Debt/Equity (mrq)

    5.76%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: